Yokogawa Electric Corporation (Tokyo: 6841) today announced the introduction of the CQ3000, a high-content analysis system for capturing high-definition 3D microscopic images of live cell cultures. Expanding the company’s CellVoyager™ family of products, the CQ3000 will be commercially available later in 2024.
The CQ3000 is designed to capture 3D microscopic images of live cell cultures in high definition at high speed. When used in conjunction with Yokogawa’s CellPathFinder image analysis software, the CQ3000 can quantify and analyze intracellular organelles to assess cellular responses and effects of drug compounds. This enables highly efficient evaluation of cells in a wide range of applications from basic research to drug discovery screening.
“CQ3000 is an extension of the CellVoyager series that will accelerate the development of new drugs and streamline fundamental research in cutting-edge biology and medicine. Through the provision of products and solutions that contribute to drug discovery research and the advancement of personalized medicine and regenerative medicine, Yokogawa aims to ensure wellness and quality of life for all.
Hiroshi Nakao, Vice President and Head of Yokogawa Electric’s Life Business Headquarters
About the CQ3000
High-definition monitoring of living cells over long periods of time
The CQ3000 enables stable and precise monitoring of live cell cultures over long periods of time with Yokogawa’s high-precision temperature control and dual spinning-disks with microlens that capture optical slice images (confocal images) with high speed and better sensitivity, which minimizes damage. in cells compared to other confocal systems on the market.
High speed screening
The CQ3000 can capture microplate images at high speed thanks to its improved stage control and auto-focus function. When used in conjunction with the optional dual camera and wide-field image capture feature, which simultaneously captures the entire field of view, image capture time is reduced. This product enables high-speed selection of promising chemical compounds from a large number of new drug candidates.
High image quality
Using Yokogawa’s proprietary water immersion lens process, in addition to detailed observation at high magnification levels, it is also possible to capture bright images at low magnification levels. Use of an optional uniformizer achieves even illumination across the entire field of view, to capture vivid images.
To know more about CQ3000 please visit: https://www.yokogawa.com/solutions/products-and-services/life-science/high-content-analysis/high-content-analysis-system-cq3000/